Palvella Therapeutics, Inc. (PVLA)
123.46
+3.08
(+2.56%)
USD |
NASDAQ |
Apr 02, 16:00
123.21
-0.25
(-0.20%)
Pre-Market: 20:00
Palvella Therapeutics Total Liabilities (Quarterly) : 31.58M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 543.42M |
| Gossamer Bio, Inc. | 295.01M |
| Agenus, Inc. | 504.66M |
| Novavax, Inc. | 1.311B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.56M |
| Shareholders Equity (Quarterly) | 27.98M |
| Debt to Equity Ratio | 0.6573 |
| Current Ratio | 5.200 |
| Net Debt Paydown Yield | -0.28% |